← Back to Search

Behavioral Intervention

Spanish-Speaking Provider for Infertility (ImpaLa Trial)

N/A
Waitlist Available
Research Sponsored by Washington University School of Medicine
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Must be greater than 18 years old
Be older than 18 years old
Must not have
Less than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 90 days from initial consultation.
Awards & highlights
No Placebo-Only Group

Summary

This trial aims to study if having a Spanish-speaking healthcare provider for Spanish-speaking patients at a Fertility and Reproductive Medicine Center affects the speed and success of fertility treatments compared to using an interpreter with

Who is the study for?
This trial is for Spanish-speaking patients experiencing infertility who are seeking treatment at Washington University's Fertility and Reproductive Medicine Center. Participants must be comfortable completing a survey in their preferred language.
What is being tested?
The study compares the effect of having a Spanish-speaking provider versus using an interpreter on the progression and outcomes of fertility treatments. It involves surveys to measure patient satisfaction and communication effectiveness.
What are the potential side effects?
Since this trial does not involve medical or pharmaceutical interventions, but rather changes in provider-patient language concordance, there are no direct side effects associated with the interventions being studied.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am over 18 years old.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I am under 18 years old.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~90 days from initial consultation.
This trial's timeline: 3 weeks for screening, Varies for treatment, and 90 days from initial consultation. for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Completion of diagnostic tests
Secondary study objectives
Patient satisfaction and communication

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Spanish-Speaking patients seen by a Spanish-speaking providerExperimental Treatment1 Intervention
Spanish speaking patients will be seen by our Spanish-speaking provider
Group II: Spanish speaking patients seen by English-Speaking ProviderActive Control1 Intervention
Spanish speaking patients will be seen by our English-speaking providers using a qualified interpreter.

Find a Location

Who is running the clinical trial?

Washington University School of MedicineLead Sponsor
1,997 Previous Clinical Trials
2,298,691 Total Patients Enrolled
~47 spots leftby Sep 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top